
Verona Pharma plc VRNA
Quartalsbericht 2025-Q2
hinzugefügt 06.08.2025
Verona Pharma plc P/CF 2011-2025 | VRNA
P/CF Jährlich Verona Pharma plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -359 | -219 | -180 | -95.6 | -5.78 M | -1.9 | -3.42 | -6.55 | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -1.9 | -5.78 M | -723 K |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
-5.18 | $ 4.89 | 3.82 % | $ 812 M | ||
|
Aclaris Therapeutics
ACRS
|
-7.59 | $ 3.25 | -0.15 % | $ 251 M | ||
|
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | ||
|
Aptevo Therapeutics
APVO
|
-0.0374 | $ 1.06 | -6.19 % | $ 293 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Ascendis Pharma A/S
ASND
|
-17.6 | $ 217.87 | -1.16 % | $ 5 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.18 | -2.93 % | $ 7.65 B | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
BioVie
BIVI
|
-0.128 | $ 1.38 | -4.61 % | $ 2.04 M | ||
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-14.6 | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
70.7 | $ 93.77 | -1.09 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
6.13 | $ 26.05 | 3.07 % | $ 1.26 B | ||
|
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | ||
|
Anika Therapeutics
ANIK
|
-209 | $ 9.58 | 0.21 % | $ 140 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-413 | $ 0.27 | -3.93 % | $ 588 M | ||
|
Catalyst Biosciences
CBIO
|
1.3 | $ 13.91 | -1.31 % | $ 916 M | ||
|
Arena Pharmaceuticals
ARNA
|
-12.5 | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
-5.78 | - | 3.77 % | $ 22.4 M | ||
|
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | ||
|
Axon Enterprise
AXON
|
97.5 | $ 548.94 | -2.72 % | $ 41.6 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-8.14 | $ 2.36 | 2.64 % | $ 14.8 M | ||
|
AstraZeneca PLC
AZN
|
13.6 | $ 91.2 | 1.53 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
-2.62 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
11.6 | $ 8.87 | -1.5 % | $ 1.45 B | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-10.3 | $ 11.36 | -1.52 % | $ 735 M | ||
|
Biogen
BIIB
|
6.73 | $ 173.9 | -0.12 % | $ 25.3 B | ||
|
Celldex Therapeutics
CLDX
|
-0.00833 | $ 27.0 | -1.87 % | $ 1.74 M | ||
|
Abeona Therapeutics
ABEO
|
-4.04 | $ 5.08 | -5.32 % | $ 109 M | ||
|
ADiTx Therapeutics
ADTX
|
-0.00353 | $ 1.68 | -25.0 % | $ 22.1 K | ||
|
Cellectar Biosciences
CLRB
|
-1.37 | $ 3.39 | -6.35 % | $ 41.4 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
-0.323 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
-2.46 | - | -7.31 % | $ 87 M | ||
|
Advaxis
ADXS
|
-0.0633 | - | -9.65 % | $ 45.9 M | ||
|
Завод ДИОД
DIOD
|
7.49 | - | - | - | ||
|
Фармсинтез
LIFE
|
-8.26 | - | - | - |